| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.62 | 0.02 |